MedTrace Logo

Real World Experience in Heart Failure With Reduced Ejection Fraction (HFrEF) Patients Treated With sAc/vaL.

NCT05448872 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 924

Last updated 2022-11-08

No results posted yet for this study

Summary

The study is a cohort observational, retrospective, non-interventional study.

Conditions

Interventions

DRUG

Sacubitril/Valsartan

HF patients treated with Sac/Val

Sponsors & Collaborators

Principal Investigators

  • Novartis Pharmaceuticals · Novartis Pharmaceuticals

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-23
Primary Completion
2021-09-15
Completion
2021-09-15

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05448872 on ClinicalTrials.gov